FDA Investigator

Maurine Fadlalla

Latest inspection on record: Riverside, United States, May 2026 · records back to 2024

BiologicsHuman Drugs

FDA inspection record · Last updated July 12, 2026

Overview

  • 45 inspections across 45 sites are on record.
  • 19 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2026-05-21.

At a glance

Inspections

45

Sites

45

Observations

19

Career since

Apr 2024

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
PLZ Corp21 May 2026Human DrugsOn file
Children's Hospital of Orange County29 Apr 2026BiologicsOn file
Aykut Bayrak, MD A Professional Corporation15 Apr 2026Biologics
Wright Medical Technology Inc - District Service Center - Tustin2 Apr 2026Biologics
Labryo Fertility Center26 Mar 2026Biologics

Sites inspected

PLZ CorpRiverside, United States1 insp.
Children's Hospital of Orange CountyOrange, United States1 insp.
Aykut Bayrak, MD A Professional CorporationLos Angeles, United States1 insp.
Wright Medical Technology Inc - District Service Center - TustinTustin, United States1 insp.
Labryo Fertility CenterNewport Beach, United States1 insp.

Co-investigators

Investigators who share inspections with this person.

Celeta S Coves4 shared
Journey V Cordero1 shared
Laurissa S Flowers1 shared
Zachary A Bogorad1 shared

Full investigator report

Get the verbatim findings behind Maurine Fadlalla's 19 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site

Related investigators